Assured Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-799
Closed -$32K 619
2019
Q1
$32K Sell
799
-68,244
-99% -$2.73M ﹤0.01% 1005
2018
Q4
$2.86M Buy
69,043
+38,813
+128% +$1.61M 0.08% 287
2018
Q3
$1.26M Buy
+30,230
New +$1.16M 0.02% 509
2018
Q2
Sell
-20,564
Closed -$692K 1285
2018
Q1
$692K Sell
20,564
-204,590
-91% -$7.03M 0.02% 668
2017
Q4
$7.74M Buy
225,154
+118,050
+110% +$4.03M 0.16% 141
2017
Q3
$3.63M Sell
107,104
-13,912
-11% -$447K 0.07% 256
2017
Q2
$3.86M Buy
+121,016
New +$3.82M 0.08% 154
2017
Q1
Sell
-18,350
Closed -$565K 699
2016
Q4
$565K Sell
18,350
-45,216
-71% -$1.38M 0.01% 433
2016
Q3
$2.04M Buy
+63,566
New +$2.13M 0.05% 179
2016
Q2
Sell
-8,797
Closed -$247K 659
2016
Q1
$247K Sell
8,797
-5,502,155
-100% -$157M 0.01% 456
2015
Q4
$169M Buy
5,510,952
+5,499,425
+47,709% +$173M 2.95% 2
2015
Q3
$343K Buy
11,527
+8,590
+292% +$275K 0.01% 426
2015
Q2
$93K Sell
2,937
-16,406
-85% -$535K ﹤0.01% 574
2015
Q1
$638K Buy
+19,343
New +$615K 0.01% 208

Other funds holding PFE

Assured Investment Management's PFE Position: Q2 2019 in Review

Assured Investment Management sold out of Pfizer (PFE) in Q2 2019, closing a stake of 799 shares — an estimated $32K sold.

Assured Investment Management first reported a position in PFE in Q1 2015 and held it in 14 quarters. The position peaked at $169M in Q4 2015. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Assured Investment Management reported no remaining Pfizer position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 799 Pfizer shares in Q2 2019, an estimated $32K.
  • Assured Investment Management first reported a position in Pfizer in Q1 2015 and held it in 14 quarters.
  • Assured Investment Management's Pfizer position peaked at $169M in Q4 2015.
  • 2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.